Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
ERMA's Recommendation To Continue The Use Of Endosulfan In New Zealand Dismays Breast Cancer Network
http://www.medicalnewstoday.com/articles/113614.php
Breast Cancer Network NZ is very disturbed that ERMA has not recommended a ban on the use of the pesticide endosulfan in New Zealand. This acutely toxic organochlorine chemical has been used so widely that it is found in our food and water and is a contaminant of the environment and animal tissues all over the world.
----------------------------------------------
** CANCER / ONCOLOGY News **
Pharmacists Urge Consumers To Seek Advice About Sunburn Safety
http://www.medicalnewstoday.com/articles/113687.php
With the incidence of skin cancer annually on the rise, the American Pharmacists Association (APhA) encourages consumers to talk to their pharmacist about sunburn prevention, sunburn treatment and medications that increase the skin's sensitivity to the sun.
Clinicians Should Consider Economic Impact Of New Interventions
http://www.medicalnewstoday.com/articles/113680.php
Cancer clinicians should understand and consider the economic impact of new interventions, which often have substantial costs, according to a report appearing in the July/August issue of <i>CA: A Cancer Journal for Clinicians</i>, a peer-reviewed journal of the American Cancer Society.
Newly Discovered Checkpoint Process Decides Between Death, Division Or Cancer
http://www.medicalnewstoday.com/articles/113670.php
Each day, a staggering number of cells perform a feat that still amazes researchers with its complexity: they divide to produce perfect replicas of each other. The process is called mitosis, and an inability to control it is one of the hallmarks of cancer.
New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of Cancers
http://www.medicalnewstoday.com/articles/113606.php
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem In Pediatric Cancer Research
http://www.medicalnewstoday.com/articles/113599.php
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
Is Pelvic Lymph Node Dissection Necessary Among Elderly Patients With Bladder Cancer Undergoing A Radical Cystectomy?
http://www.medicalnewstoday.com/articles/113561.php
ORLANDO, FL (UroToday.com) - Extension of the pelvic lymph node dissection (PLND) during radical cystectomy (RC) has been proposed to improve patient survival and optimize lymph node count, a potential indicator of surgical quality.
Pseudosarcomatous Fibromyxoid Tumor Of The Bladder
http://www.medicalnewstoday.com/articles/113552.php
UroToday.com - We recently reported on the workup and treatment of a benign bladder lesion termed pseudosarcomatous fibromyxoid tumor of the bladder. One of goals of the manuscript was the description of conservative surgical treatment of localized bladder lesions, which could be malignant or benign.
Prognostic Impact Of Postoperative C-Reactive Protein Level In Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy
http://www.medicalnewstoday.com/articles/113551.php
UroToday.com - The presence of a systemic inflammatory reaction, represented by C-reactive protein (CRP), has been recognized as one of the negative prognostic factors in various malignancies.
DxS Launches Cancer Mutation Kit For K-RAS In Australia - New Diagnostic Assists Clinicians In Selecting Appropriate Cancer Therapy For Patients
http://www.medicalnewstoday.com/articles/113529.php
DxS, a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the launch of its K-RAS cancer mutation detection kit in Australia. This follows the kit meeting the compliance standards of Australia's Therapeutic Goods Administration (TGA).
How To Move Cancer Research Forward: Public/Private Partnerships - A NCI Science Writer's Seminar
http://www.medicalnewstoday.com/articles/113524.php
<b>What</b>br> Please join us for a science writers' seminar to discuss public/private partnerships in cancer research. Among the topics discussed will be working with industry to develop new drugs; cancer vaccine development and business barriers; working with small businesses to develop new technologies to catch cancer in its earliest stages; and intellectual property rights and technology transfer issues related to new genetic tests.
New High-Tech Imaging Center "TIGA" At The University Of Heidelberg / Robot "NanoZoomer" Shows High-Resolution Images Of Cells And Tissue
http://www.medicalnewstoday.com/articles/113523.php
"TIGA," the new high-tech imaging center at the University of Heidelberg founded in cooperation with the Japanese company Hamamatsu, provides deep insights: a high-tech robot makes it possible for the first time to automatically reproduce and evaluate tissue slices only micromillimeters thick - an important aid for researchers in understanding cancer or in following in detail the effect of treatment on cells and tissue.
Yeast-Based Vaccine Induces Immune Responses And Reduces Tumor Size In Mice
http://www.medicalnewstoday.com/articles/113522.php
Scientists have found that vaccination with a heat-killed, nontoxic yeast that is genetically engineered to manufacture a common tumor protein can induce specific and repeated anti-tumor immune responses in mice.
First Analysis Of Cancer Incidence, Mortality And Survival Combined Reveals Encouraging Trends In Europe, Smoking And Obesity-Related Cancers Increase
http://www.medicalnewstoday.com/articles/113509.php
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction.
At Specific Signal Threshold, Cancer Cells Revert To Normal
http://www.medicalnewstoday.com/articles/113501.php
Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state.
Sunburn Alert: UVB Does More Damage To DNA Than UVA
http://www.medicalnewstoday.com/articles/113490.php
As bombs burst in air this July 4, chances are that sunburn will be the red glare that most folks see - and feel. But unfortunately, even when there is no burn, the effects of the sun's ultraviolet (UV) rays can have deadly consequences.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Will Chemotherapy Work? Einstein Researchers Develop Test That May Offer Answer For Colorectal Patients
http://www.medicalnewstoday.com/articles/113671.php
By measuring the activity of four genes in cancer cells, scientists at theAlbert Einstein College of Medicine of Yeshiva University accurately predicted whether colorectal tumorsare sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial Of CoFactor(R)
http://www.medicalnewstoday.com/articles/113598.php
ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU (5 fluorouracil), for the treatment of first-line metastatic colorectal cancer.
Low Use Of Medical Check-Ups For Intestinal Cancer
http://www.medicalnewstoday.com/articles/113491.php
Only 20% of persons aged over 55 use colonoscopies for early detection of cancer, even though the statutory health insurance funds have covered the costs since 2002. This was shown by an analysis of the Bavarian Colonoscopy Database published in the current edition of <i>Deutsches Arzteblatt International </i>(Dtsch Arztebl Int 2008; 105(24): 434-40).
----------------------------------------------
** LUNG CANCER News **
Smoke-Free Policies Are Achieving Intended Goals
http://www.medicalnewstoday.com/articles/113489.php
A new article published in <i>The Lancet Oncology</i>claims that the recent smoke-free policy initiatives have resulted innumerous public health gains. The special report from the InternationalAgency for Cancer Research (IARC) reveals that thepolicies have been instrumental in reducing heart disease related tosmoke exposure, diminishing the number of adults who smoke, and curbingsecond-hand smoke exposure to adults and children.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial Of Dacogen(R) Versus Supportive Care In Patients With Myelodysplastic Syndromes
http://www.medicalnewstoday.com/articles/113584.php
Eisai Corporation of North America announced the preliminary efficacy data from a trial initiated in 2002 comparing Dacogen(R) (decitabine) to Best Supportive Care (BSC) in elderly patients with myelodysplastic syndromes (MDS).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
With Prostate Cancer: Waiting For Symptoms Is Not An Option
http://www.medicalnewstoday.com/articles/113602.php
Prostate cancer is the second leading cause of death among American males, but when caught early, prostate cancer has a 90% cure rate. According to Dr. David Samadi, Chief, Division of Robotics and Minimally Invasive Surgery, Department of Urology, at Mount Sinai Medical Center, "The key to fighting prostate cancer is not to wait until there are warning signs, because by then it may be too late.
Take Home Message - Advanced Prostate Cancer - Reported From The Annual Meeting Of The American Urological Association
http://www.medicalnewstoday.com/articles/113574.php
ORLANDO, FL (UroToday.com) - Highlights of the advance prostate cancer session included; effectiveness of salvage radiation therapy for a rising PSA after radical prostatectomy, role of an extended lymph node dissection, dutesteride for rising PSA, use of anti-PSMA monoclonal antibodies for hormone-refractory prostate cancer, and long-term side effects of androgen deprivation.
Take Home Message - Localized Prostate Cancer - Reported From The Annual Meeting Of The American Urological Association
http://www.medicalnewstoday.com/articles/113573.php
ORLANDO, FL (UroToday.com) - There were many interesting presentations this year. Highlights included PSA follow-up protocols after radical prostatectomy, predictors of incontinence after prostate surgery, adjuvant radiation therapy, and high-intensity frequency ultrasound for the treatment of focal prostate cancer.
Radical Retropubic Prostatectomy For Localized Prostate Cancer In Renal Transplant Patients
http://www.medicalnewstoday.com/articles/113555.php
UroToday.com - In the online issue of Urology, Dr. Antonopoulos and colleagues from Brazil present an approach for surgical treatment of localized prostate cancer (CaP) in men who have already undergone renal transplantation.
Positive Surgical Margins During Robotic Radical Prostatectomy: A Contemporary Analysis Of Risk Factors
http://www.medicalnewstoday.com/articles/113554.php
UroToday.com - In the online version of the BJU International, Dr. Liss and colleagues assess the risk factors associated with a positive surgical margin (PSM) that can occur during robotic radical prostatectomy (RARP).
Intensity-Modulated Radiotherapy Of The Prostate After Cryotherapy: Initial Experience
http://www.medicalnewstoday.com/articles/113550.php
UroToday.com - Cryotherapy has benefited from many technical advances in recent years. "Third generation" delivery systems have significantly decreased the rate of complications resulting in a renewed interest in cyrotherapy for treatment of localized prostate cancer.
Analyzing The Occurrence Of Peyronie's Disease After Radical Prostatectomy
http://www.medicalnewstoday.com/articles/113545.php
ORLANDO, FL (UroToday.com) - Dr. Matthias Heck, et al. examined the occurrence of Peyronie's disease (PD) after radical prostatectomy. The incidence of PD in the general population is estimated to be between 3-9%.
Football Hero Sir Geoff Hurst MBE Urges: Access To Prostate Cancer Care Shouldn't Be Left To Chance
http://www.medicalnewstoday.com/articles/113542.php
World Cup legend Sir Geoff Hurst, MBE, backed by leading doctors, MPs and patient groups today appealed for all men with prostate cancer to get access to the best care as it emerged 7 out of 10 with advanced disease do not receive chemotherapy despite being eligible for treatment.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment